Emmis Acquisition【EMIS】銘柄情報

Emmis Acquisition Corporation (EMIS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

10.18

( 0.69% )

買値

10.11

売値

10.18

出来高

5,006

10.18 日の範囲 10.18

1.05 52 週間の範囲 10.18

時価総額

160.598M

前日終値

10.11

始値

10.18

時刻

10.18

最終取引時間

23:29:49

財務取引量

US$ 50,961

VWAP

10.18

平均取引量 (3 か月)

US$ 13,721

発行済株式数

15,775,833

配当利回り

PER

1 株当たり利益 (EPS)

歳入

純利益

1.12M

Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Emmis Acquisition Corp. was incorporated in 2025 and is based in Fort Lauderdale, Florida. Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Emmis Acquisition Corp. was incorporated in 2025 and is based in Fort Lauderdale, Florida.

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.emmisacquisition.com

本社

Fort Lauderdale, United States

設立

2026

Emmis Acquisition Corporation is listed in the Healthcare sector of the ナスダック市場 with ticker EMIS. The last closing price for Emmis Acquisition was US$10.11. Over the last year, Emmis Acquisition shares have traded in a share price range of US$ 1.05 to US$ 10.18.

Emmis Acquisition currently has 15,775,833 shares in issue. The market capitalisation of Emmis Acquisition is US$160.60 million.

Sichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference Carmel LLP (“SRFC”) reported that in 2025...

Novo Nordisk And Emisphere Sign Insulin Licensing Deal

Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) said Tuesday it has entered a development and licensing agreement with U.S.-based...

Emisphere Technologies, Inc. Receives NASDAQ Panel Decision

Emisphere Technologies, Inc. (NASDAQ: EMIS) today announced that it received notification from the NASDAQ Stock Market that its...

Emisphere Technologies Announces the Completion of Enrollment in Second Phase III Study for Oral Osteoarthritis Treatment Uti...

Emisphere Technologies, Inc. (NASDAQ: EMIS) announced today that Novartis Pharma AG and Nordic Bioscience have completed...

Emisphere Technologies Reports Encouraging Data from Independent Clinical Study Assessing the Effects of Oral GLP-1 & PYY3-36...

Emisphere Technologies, Inc. (NASDAQ: EMIS) today announced data from a clinical study designed to assess the effect of oral...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.03	0.295566502463	10.15	10.18	10.11	3028	10.11002907	CS
4	0.05	0.493583415597	10.13	10.18	10.11	1062	10.12000991	CS
12	0.13	1.29353233831	10.05	10.18	10.04	3015	10.10378672	CS
26	0.23	2.31155778894	9.95	10.18	9.95	5301	10.05290463	CS
52	9.13	869.523809524	1.05	10.18	1.05	11974	9.97507682	CS
156	9.13	869.523809524	1.05	10.18	1.05	3991	9.97507682	CS
260	9.13	869.523809524	1.05	10.18	1.05	2391	9.97507682	CS